Candel Therapeutics, Inc.
CADL
Revenue
32.00k
▲1.00k▲3.23%
3 Months ChangeAssets
93.60M
▼-12.37M▼-11.67%
3 Months ChangeLiabilities
13.47M
▼-2.28M▼-14.49%
3 Months ChangeFree Cash Flow
-8.62M
▼-174.00k▼-2.06%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-23
Form 8-K
ID: 0001193125-26-062490
2026-02-19
Form 8-K
ID: 0001193125-26-059334
2025-12-05
Form 8-K
ID: 0001193125-25-308719
2025-11-13
Form 10-Q
ID: 0001193125-25-279086
2025-11-13
Form 8-K
ID: 0001193125-25-279072
2025-10-14
Form 8-K
ID: 0001193125-25-238254
2025-08-21
Form 8-K
ID: 0000950170-25-110682
2025-08-14
Form 10-Q
ID: 0000950170-25-108450
2025-08-14
Form 8-K
ID: 0000950170-25-108448
2025-06-24
Form 8-K
ID: 0001193125-25-145405